Cargando…

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin

BACKGROUND: Endothelial activation and damage occur early during sepsis, with activated coagulopathy and playing a major role in the pathophysiology of sepsis-induced acute kidney injury (AKI). The aim of this study was to compare the various biomarkers of endothelial injury with the biomarkers of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katayama, Shinshu, Nunomiya, Shin, Koyama, Kansuke, Wada, Masahiko, Koinuma, Toshitaka, Goto, Yuya, Tonai, Ken, Shima, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574079/ https://www.ncbi.nlm.nih.gov/pubmed/28841902 http://dx.doi.org/10.1186/s13054-017-1815-x

Ejemplares similares

Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis
por: Katayama, Shinshu, et al.
Publicado: (2019)

Body weight definitions for evaluating a urinary diagnosis of acute kidney injury in patients with sepsis
por: Katayama, Shinshu, et al.
Publicado: (2018)

Influence of contrast media on renal function and outcomes in patients with sepsis-associated acute kidney injury: a propensity-matched cohort study
por: Goto, Yuya, et al.
Publicado: (2019)

Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
por: Katayama, Shinshu, et al.
Publicado: (2018)

Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis
por: Koyama, Kansuke, et al.
Publicado: (2018)

Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors
por: Koyama, Kansuke, et al.
Publicado: (2019)

Predictive factors for successful INTELLiVENT-ASV® use: a retrospective observational study
por: Katayama, Shinshu, et al.
Publicado: (2020)

Accuracy of two pulse-oximetry measurements for INTELLiVENT-ASV in mechanically ventilated patients: a prospective observational study
por: Katayama, Shinshu, et al.
Publicado: (2021)

Hyperlactatemia caused by intra-venous administration of glycerol: A case study
por: Katayama, Shinshu, et al.
Publicado: (2012)

Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study
por: Tonai, Ken, et al.
Publicado: (2022)

Concurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case report
por: Koinuma, Toshitaka, et al.
Publicado: (2014)

Upper Arm Muscular Echogenicity Predicts Intensive Care Unit-acquired Weakness in Critically Ill Patients
por: Naoi, Tameto, et al.
Publicado: (2022)

Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study
por: Koyama, Kansuke, et al.
Publicado: (2014)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
por: Koyama, Kansuke, et al.
Publicado: (2017)

Airway opening pressure in an obese ARDS patient: just the start of airway recruitment
por: Katayama, Shinshu, et al.
Publicado: (2023)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Value of Serum Thrombomodulin as a Marker and Predictor in Patients with Sepsis-Associated Acute Kidney Injury
por: Nguyen, Van Tri, et al.
Publicado: (2023)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients
por: Miyoshi, Seigo, et al.
Publicado: (2014)

Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury
por: Li, Qin, et al.
Publicado: (2021)

Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury
por: Nozaki, Yuji, et al.
Publicado: (2020)

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
por: Iba, Toshiaki, et al.
Publicado: (2009)

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
por: Yamakawa, Kazuma, et al.
Publicado: (2011)

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2013)

Use of Recombinant Human Soluble Thrombomodulin in Patients with Sepsis-Induced Disseminated Intravascular Coagulation after Intestinal Perforation
por: Tagami, Takashi, et al.
Publicado: (2015)

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
por: Kato, Takahiro, et al.
Publicado: (2018)

Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release
por: Akatsuka, Masayuki, et al.
Publicado: (2020)

Thrombomodulin: A Bifunctional Modulator of Inflammation and Coagulation in Sepsis
por: Okamoto, Takayuki, et al.
Publicado: (2012)

Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
por: Drożdż, Dorota, et al.
Publicado: (2018)

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
por: Kudo, Daisuke, et al.
Publicado: (2021)

Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
por: Okamoto, Takayuki, et al.
Publicado: (2020)

Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
por: van Aanhold, Cleo C. L., et al.
Publicado: (2021)

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest
por: Zhang, Boya, et al.
Publicado: (2023)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2015)

Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study
por: Kato, Takahiro, et al.
Publicado: (2013)

Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy
por: Levi, Marcel, et al.
Publicado: (2020)

Effects of recombinant human soluble thrombomodulin on neutrophil extracellular traps in the kidney of a mouse model of endotoxin shock
por: Harada, Tatsuhiko, et al.
Publicado: (2023)

A Thrombomodulin Promoter Gene Polymorphism, rs2239562, Influences Both Susceptibility to and Outcome of Sepsis
por: Watanabe, Eizo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5sf22c20e962iuknhui2ajm4d